Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $295 Million - $362 Million
-1,491,285 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $5.95 Million - $7.89 Million
-32,653 Reduced 2.14%
1,491,285 $302 Million
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $288 Million - $371 Million
1,523,938 New
1,523,938 $367 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Winslow Capital Management, LLC Portfolio

Follow Winslow Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winslow Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winslow Capital Management, LLC with notifications on news.